Thrombocythemia, Essential

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Hematologic Diseases, Myeloproliferative Disorders

Treatments and conditions

Thrombocythemia, Essential
Treatment and conditionWhere it standsTrials
Givinostat for thrombocythemia, essentialTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Peginterferon α-2b injection for thrombocythemia, essentialPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ROPEGINTERFERON ALFA-2B for thrombocythemia, essentialPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.